GlassScriptPhysician profile
Louisa Ringor Capicio
NPI 1558945485
$12,704.05
in general payments reported to CMS, 2019-2025
19 companies · $1,888 in 2025
The $1,888 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.89 · 2022: $5,741 · 2023: $3,605 · 2024: $1,435 · 2025: $1,888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,265 · Education: $976 · Travel and Lodging: $686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,265.16 |
| Education | $976.18 |
| Travel and Lodging | $686.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,001.96 | 2022-2025 | Primeadvanced Surescan |
| Painteq LLC | $2,058.30 | 2022-2024 | Painteq |
| Nevro Corp. | $1,874.71 | 2021-2024 | Senza |
| Boston Scientific Corporation | $1,302.32 | 2022-2025 | Intracept, General - Pain Management |
| Globus Medical, INC. | $1,185.77 | 2025 | Senza, Vyrsa V1 |
| Relievant Medsystems, INC. | $1,103.65 | 2022-2023 | Intracept |
| Spinal Simplicity, LLC | $1,064.24 | 2022-2025 | Ha Minuteman G3-R |
| Averitas Pharma INC. | $385.29 | 2023-2025 | Qutenza |
| Si-Bone, INC. | $181.11 | 2023-2025 | |
| Abbvie INC. | $162.21 | 2022 | |
| Bioventus LLC | $89.12 | 2022-2023 | Stimrouter Implantable Kit |
| Grt US Holding, INC. | $80.55 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $65.43 | 2022-2023 | |
| Nalu Medical, INC. | $47.78 | 2022-2024 | Nalu Neurostimulation System |
| Biohaven Pharmaceutical Holding Company LTD. | $34.22 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $22.34 | 2023 | Belbuca |
| Horizon Therapeutics Plc | $15.94 | 2022 | |
| Scilex Pharmaceuticals INC. | $15.09 | 2022 | |
| Bausch Health US, LLC | $14.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louisa Capicio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.